Table 5.

Sensitivity and specificity for leukemia classification using SVM in 13 subgroups



Patients and controls (N = 937)

Sensitivity, %

Specificity, %
Leukemia classification
Median
95% CI
Median
95% CI
c-ALL/pre-B-ALL   82   92.9   82.1-100   99.7   98.6-100  
Pro-B-ALL with t(11q23)   26   100   77.8-100   100   100-100  
Mature B-ALL with t(8;14)   12   75   25-100   100   99.4-100  
T-ALL   32   90   70-100   100   99.7-100  
AML with t(15;17)   42   100   100-100   100   100-100  
AML with t(8;21)   38   100   83.3-100   100   99.7-100  
AML with inv(16)   49   100   87.5-100   100   100-100  
AML with t(11q23)   47   81.3   62.5-100   99.7   99-100  
AML with complex karyotype   75   86   72-96   99.7   98.6-100  
AML normal/other   369   96.8   94.3-99.2   93.7   90.2-96.6  
CLL   45   100   93.3-100   100   100-100  
CML   75   96   84-100   99.7   98.6-100  
Nonleukemia
 
45
 
90
 
66.3-100
 
99.7
 
98.3-100
 


Patients and controls (N = 937)

Sensitivity, %

Specificity, %
Leukemia classification
Median
95% CI
Median
95% CI
c-ALL/pre-B-ALL   82   92.9   82.1-100   99.7   98.6-100  
Pro-B-ALL with t(11q23)   26   100   77.8-100   100   100-100  
Mature B-ALL with t(8;14)   12   75   25-100   100   99.4-100  
T-ALL   32   90   70-100   100   99.7-100  
AML with t(15;17)   42   100   100-100   100   100-100  
AML with t(8;21)   38   100   83.3-100   100   99.7-100  
AML with inv(16)   49   100   87.5-100   100   100-100  
AML with t(11q23)   47   81.3   62.5-100   99.7   99-100  
AML with complex karyotype   75   86   72-96   99.7   98.6-100  
AML normal/other   369   96.8   94.3-99.2   93.7   90.2-96.6  
CLL   45   100   93.3-100   100   100-100  
CML   75   96   84-100   99.7   98.6-100  
Nonleukemia
 
45
 
90
 
66.3-100
 
99.7
 
98.3-100
 

Overall median accuracy was 93.8% (95% CI, 91.4%-95.8%).

Close Modal

or Create an Account

Close Modal
Close Modal